Covid-19: China’s first vaccine enters phase 2 clinical trials

Coronavirus COVID-19

China’s first inactivated vaccine developed by China National Biotec Group has entered Phase II clinical trials.

clinical trials

According to Global Times on Friday, the 96 volunteers who received the vaccine in Phase I trials are in good condition.

Senate passes additional $484bn COVID-19 relief package

China begun the second phase of clinical trials for a COVID-19 vaccine with 500 volunteer participants recruited from Wuhan, the initial epicenter of the outbreak, according to state media.

It is the first Phase 2 human test for a COVID-19 vaccine in the global race to find a cure for the pandemic, the official Xinhua News Agency said recently.

According to Voice of America, China completed its Phase 1 trial at the end of March with 108 volunteers.  All of them reportedly have been released from medical observation and are in good health.

While the first phase focused on the vaccine’s safety, the second phase inoculates many more people to determine how effective it is in protecting against infection.

About the author

Nneka

Leave a Comment